By CHAD BRAY
The British pharmaceutical company said it will pay $875 million to the Spanish drug maker Almirall and up to $1.22 billion more for various development and sales-related milestones.
Published: July 30, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1rFejGm
from WordPress http://ift.tt/1AxL0LZ
via Hadi Aboukhater
No comments:
Post a Comment